Audited Supplier
D-sung Thymosin alpha 1
Yes
Customized
GMP, HSE, ISO 9001, USP, BP
Elderly, Children, Adult
Powder
>99%
Thymosin Alpha 1
Thymalfasin
White Powder
White
Pharmaceutical Grade
HPLC 99%
Pharmaceutical
COA
HPLC
2 Years
62304-98-7
C129h215n33o55
3108.2755
1.360±0.06 g/cm3
2899.7±65.0 °c
D-sung
Negotiable
99%
Shaanxi Xi'an
Product Description
Raw Powder CAS 62304-98-7 Thymosin alpha 1 Hormone Peptide Thymosin Alpha 1 Muscle Building Thymalfasin
| Product name | Thymosin alpha 1 |
| Appearance | White powder |
| CAS NO. | 62304-98-7 |
| MF | C129H215N33O55 |
| MW | 3108.2755 |
Thymalfasin (thymosin-α1) is an immunomodulatory agent that is able to augment some specific T lymphocyte functions, particularly that of promoting the T helper 1 cell responses involved in host antiviral defence. The most promising clinical applications for thymalfasin seem to be as a single agent for the treatment of chronic hepatitis B and in combination with interferon-α for the treatment of both chronic hepatitis B and C. These positive preliminary results offer a strong rationale for larger, well-planned clinical trials and also for defining the optimal schedule of administration.
1. For the treatment of chronic hepatitis B.
2. A vaccine immune response enhancer as an immunocompromised patient. Immune system function is inhibited, including chronic hemodialysis and elderly patients, this product can enhance the immune response of patients with viral vaccines, such as influenza vaccine or hepatitis B vaccine.
A number of in vitro tests showed that the goods through the stimulation of peripheral blood lymphocytes promoting T lymphocyte mitogen original maturity, increase antigen or mitogen-activated T cells secrete interferon-α, interferon-γ and interleukin-2, interleukin-3, etc. lymphokines level, while increasing the T cell surface receptor level lymphokines. This product can also through the activation of CD4 cells, enhancing human allogeneic and autologous mixed lymphocyte reaction. It can be used to increase NK cells before aggregation, and enhanced cytotoxicity interferon can make it. In vivo tests showed that product can increase by Con A activated lymphocytes in mice interleukin-2 receptor expression levels, while increasing the secretion of interleukin-2 levels.
1. For the treatment of chronic hepatitis B.2. A vaccine immune response enhancer as an immunocompromised patient. Immune system function is inhibited, including chronic hemodialysis and elderly patients, this product can enhance the immune response of patients with viral vaccines, such as influenza vaccine or hepatitis B vaccine.
A number of in vitro tests showed that the goods through the stimulation of peripheral blood lymphocytes promoting T lymphocyte mitogen original maturity, increase antigen or mitogen-activated T cells secrete interferon-α, interferon-γ and interleukin-2, interleukin-3, etc. lymphokines level, while increasing the T cell surface receptor level lymphokines. This product can also through the activation of CD4 cells, enhancing human allogeneic and autologous mixed lymphocyte reaction. It can be used to increase NK cells before aggregation, and enhanced cytotoxicity interferon can make it. In vivo tests showed that product can increase by Con A activated lymphocytes in mice interleukin-2 receptor expression levels, while increasing the secretion of interleukin-2 levels.
